Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Cash from Operations (2019 - 2026)

ADC Therapeutics has reported Cash from Operations over the past 8 years, most recently at 29710000.0 for Q1 2026.

  • Quarterly results put Cash from Operations at 29710000.0 for Q1 2026, up 47.26% from a year ago — trailing twelve months through Mar 2026 was 114550000.0 (up 15.82% YoY), and the annual figure for FY2025 was 141174000.0, down 14.0%.
  • Cash from Operations reached 29710000.0 in Q1 2026 per ADCT's latest filing, up from 31123000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2195.0 in Q3 2022 and bottomed at 138226303.0 in Q4 2022.
  • Median Cash from Operations over the past 5 years was 29710000.0 (2026), compared with a mean of 32453882.35.
  • The largest annual shift saw Cash from Operations surged 103.75% in 2022 before it plummeted 1670851.71% in 2023.
  • Over 5 years, Cash from Operations stood at 138226303.0 in 2022, then surged by 77.12% to 31633000.0 in 2023, then skyrocketed by 30.92% to 21852000.0 in 2024, then plummeted by 42.43% to 31123000.0 in 2025, then increased by 4.54% to 29710000.0 in 2026.
  • Business Quant data shows Cash from Operations for ADCT at 29710000.0 in Q1 2026, 31123000.0 in Q4 2025, and 29630000.0 in Q3 2025.